Private Equity

Managers

Payments company Nvoicepay looks to raise more money

1 min read · 18 October 2018

Portfolia’s FemTech Fund: Women investing in women’s health

5 min read · 18 October 2018

Fertility care services provider Future Family raises $10 mln led by Aspect Ventures

San Francisco-based Future Family, a provider of fertility care services, has raised $10 million in a Series A round of funding led by Aspect Ventures. Also participating in the round are iNovia Capital, BBG Ventures, LaunchCapital, Ulu Ventures and Portfolia's FemTech Fund. Future Family, which provides a monthly payment service for such fertility services as egg freezing, in vitro fertilization and concierge care, has now raised $14.2 million in total funding. As part of the latest round, Aspect Ventures Partner Lauren Kolodny will join the board.

1 min read · 18 October 2018

Monthly recap of VC fundraising activity through Oct. 17

7 min read · 18 October 2018

VC-backed PhaseBio goes public

Pennsylvania-based PhaseBio Pharmaceuticals, a developer of treatments for orphan diseases, has raised $46 million for its IPO after pricing its 9.2 million shares at $5 per share. The stock began trading October 18, 2018 on the NASDAQ under the ticker symbol "PHAS." Citigroup, Cowen and Stifel are the lead underwriters. PhaseBio's pre-IPO backers included New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson and Fletcher Spaght Ventures.

2 min read · 18 October 2018

Baltic fund aims to blossom in wake of Skype’s success

3 min read · 18 October 2018

Finnish medical device company Synoste procures funding

Synoste Ltd, a Finnish medical device company, has raised over 5 million euros in funding. The investors were Lifeline Ventures and AO Invest.

1 min read · 18 October 2018

Fairview Capital loses third partner in two years — but not faith of Connecticut pension

3 min read · 18 October 2018

September Dashboard: IPOs soar in September; other indices fall

2 min read · 17 October 2018

French biotech firm Acticor Biotech snags Series B funding

French biotech firm Acticor Biotech has secured 15.3 million euros in Series B funding. Newton BioCapital led the round with participation from other investors that included Mirae Capital, CMS Medical Venture Investment Limited, A&B (HK) and CapDecisif Management.

1 min read · 17 October 2018

Showing 3,201 to 3,210 of 19,970 results
1…320322…1000